Immediate multivessel percutaneous coronary intervention (PCI) was noninferior to delayed multivessel PCI – but did show statistical significance – in reducing clinical events at 1 year post-procedure in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD), new trial findings show.